ATE174592T1 - Sulfonamide und derivate zur modulierung der endothelin aktivitat - Google Patents

Sulfonamide und derivate zur modulierung der endothelin aktivitat

Info

Publication number: ATE174592T1
Authority: AT; Austria
Prior art keywords: sulfonamides; derivatives; endothelin activity; modulating endothelin; activity
Prior art date: 1993-05-20

Application number

AT94918081T

Other languages

English (en)

Inventor

Ming Fai Chan

Bore Gowda Raju

Adam Kois

Erik Joel Verner

Chengde Wu

Rosario Silvestre Castillo

Venkatachalapathi Yalamoori

Vitukudi Narayanaiyenga Balaji

Kalyanara-Man Ramnarayan

Original Assignee

Texas Biotechnology Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-05-20

Filing date

1994-05-20

Publication date

1999-01-15

1993-10-21 Priority claimed from US08/142,552 external-priority patent/US5514691A/en

1993-10-21 Priority claimed from US08/142,159 external-priority patent/US5464853A/en

1994-05-20 Application filed by Texas Biotechnology Corp filed Critical Texas Biotechnology Corp

1999-01-15 Application granted granted Critical

1999-01-15 Publication of ATE174592T1 publication Critical patent/ATE174592T1/de

Links

102000002045 Endothelin Human genes 0.000 title abstract 2
108050009340 Endothelin Proteins 0.000 title abstract 2
ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 title abstract 2
229940124530 sulfonamide Drugs 0.000 title 1
150000003456 sulfonamides Chemical class 0.000 title 1
ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 2
235000010290 biphenyl Nutrition 0.000 abstract 1
239000004305 biphenyl Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000001624 naphthyl group Chemical group 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
- C07D261/16—Benzene-sulfonamido isoxazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

AT94918081T 1993-05-20 1994-05-20 Sulfonamide und derivate zur modulierung der endothelin aktivitat ATE174592T1 (de)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US6520293A	1993-05-20	1993-05-20
US10056593A	1993-07-30	1993-07-30
US10012593A	1993-07-30	1993-07-30
US14263193A	1993-10-21	1993-10-21
US08/142,552 US5514691A (en)	1993-05-20	1993-10-21	N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
US08/142,159 US5464853A (en)	1993-05-20	1993-10-21	N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US08/222,287 US5591761A (en)	1993-05-20	1994-04-05	Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin

Publications (1)

Publication Number	Publication Date
ATE174592T1 true ATE174592T1 (de)	1999-01-15

Family

ID=27568241

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94918081T ATE174592T1 (de)	1993-05-20	1994-05-20	Sulfonamide und derivate zur modulierung der endothelin aktivitat

Country Status (13)

Country	Link
US (1)	US5591761A (de)
EP (3)	EP0870764A1 (de)
JP (1)	JP3135922B2 (de)
AT (1)	ATE174592T1 (de)
CA (1)	CA2161346C (de)
CY (1)	CY2124B1 (de)
DE (1)	DE69415316T2 (de)
DK (1)	DK0699191T3 (de)
ES (1)	ES2127397T3 (de)
GB (1)	GB2285625B (de)
RU (1)	RU2151144C1 (de)
SG (1)	SG48742A1 (de)
WO (1)	WO1994027979A1 (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5962490A (en)	1987-09-25	1999-10-05	Texas Biotechnology Corporation	Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5514696A (en) *	1992-05-06	1996-05-07	Bristol-Myers Squibb Co.	Phenyl sulfonamide endothelin antagonists
US6613804B2 (en)	1993-05-20	2003-09-02	Encysive Pharmaceuticals, Inc.	Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6342610B2 (en)	1993-05-20	2002-01-29	Texas Biotechnology Corp.	N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6541498B2 (en)	1993-05-20	2003-04-01	Texas Biotechnology	Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6030991A (en) *	1993-05-20	2000-02-29	Texas Biotechnology Corp.	Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6376523B1 (en)	1994-05-20	2002-04-23	Texas Biotechnology Corporation	Benzenesulfonamides and the use thereof to modulate the activity of endothelin
GB9504854D0 (en) *	1994-03-31	1995-04-26	Zeneca Ltd	Nitrogen derivatives
GB9409618D0 (en) *	1994-05-13	1994-07-06	Zeneca Ltd	Pyridine derivatives
US5612359A (en) *	1994-08-26	1997-03-18	Bristol-Myers Squibb Company	Substituted biphenyl isoxazole sulfonamides
US5780473A (en) *	1995-02-06	1998-07-14	Bristol-Myers Squibb Company	Substituted biphenyl sulfonamide endothelin antagonists
CA2168154A1 (en) *	1995-02-06	1996-08-07	Natesan Murugesan	Substituted biphenyl sulfonamide endothelin antagonists
US5760038A (en) *	1995-02-06	1998-06-02	Bristol-Myers Squibb Company	Substituted biphenyl sulfonamide endothelin antagonists
DE19509950A1 (de) *	1995-03-18	1996-09-19	Merck Patent Gmbh	Endothelin-Rezeptor-Antagonisten
ATE243203T1 (de) *	1995-04-04	2003-07-15	Texas Biotechnology Corp	Thienyl-, furyl-, pyrrolyl- und biphenylsulfonamide und derivate zur modulation der endothelin-aktivität
UA58494C2 (uk)	1995-06-07	2003-08-15	Зенека Лімітед	Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну
GB9512697D0 (en) *	1995-06-22	1995-08-23	Zeneca Ltd	Heterocyclic compounds
US5846990A (en) *	1995-07-24	1998-12-08	Bristol-Myers Squibb Co.	Substituted biphenyl isoxazole sulfonamides
JPH09124620A (ja) *	1995-10-11	1997-05-13	Bristol Myers Squibb Co	置換ビフェニルスルホンアミドエンドセリン拮抗剤
JP3087968B2 (ja)	1995-12-20	2000-09-18	山之内製薬株式会社	アリールエテンスルホンアミド誘導体及びその医薬組成物
US5977117A (en) *	1996-01-05	1999-11-02	Texas Biotechnology Corporation	Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
US5856507A (en) *	1997-01-21	1999-01-05	Bristol-Myers Squibb Co.	Methods for the preparation of biphenyl isoxazole sulfonamides
JP2001523218A (ja)	1996-02-20	2001-11-20	ブリストル―マイヤーズ・スクイブ・カンパニー	ビフェニルイソキサゾール・スルホンアミドの製造法
DE19606980A1 (de) *	1996-02-24	1997-08-28	Merck Patent Gmbh	Endothelin-Rezeptor-Antagonisten
US5958905A (en)	1996-03-26	1999-09-28	Texas Biotechnology Corporation	Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US5939446A (en) *	1996-04-09	1999-08-17	Bristol-Myers Squibb Co.	Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
US5804585A (en) *	1996-04-15	1998-09-08	Texas Biotechnology Corporation	Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
US5877193A (en) *	1996-07-19	1999-03-02	Hoffmann-La Roche Inc.	Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
JP4125787B2 (ja) *	1996-07-23	2008-07-30	塩野義製薬株式会社	新規ピリミジン化合物および医薬組成物
TW536540B (en) *	1997-01-30	2003-06-11	Bristol Myers Squibb Co	Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
WO1998033781A1 (en) *	1997-01-30	1998-08-06	Bristol-Myers Squibb Company	Method for preventing or treating low renin hypertension by administering an endothelin antagonist
US5783705A (en) *	1997-04-28	1998-07-21	Texas Biotechnology Corporation	Process of preparing alkali metal salys of hydrophobic sulfonamides
JP3455233B2 (ja) *	1997-04-28	2003-10-14	テキサス・バイオテクノロジー・コーポレイシヨン	エンドテリン介在障害治療用のスルホンアミド類
GB9725138D0 (en) *	1997-11-27	1998-01-28	Pharmacia & Upjohn Spa	Thiophenesulfonamide compounds
JP2002509143A (ja) *	1998-01-16	2002-03-26	センターファーマシューティカルズ，インコーポレイテッド	チオエーテルフランニトロン化合物
US6638937B2 (en)	1998-07-06	2003-10-28	Bristol-Myers Squibb Co.	Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
AU3718900A (en)	1999-03-19	2000-10-09	Bristol-Myers Squibb Company	Methods for the preparation of biphenyl isoxazole sulfonamides
US7566452B1 (en)	1999-05-04	2009-07-28	New York University	Cancer treatment with endothelin receptor antagonists
MXPA02006461A (es)	1999-12-31	2003-09-05	Texas Biotechnology Corp	Sulfonamidas y derivados de las mismas que modulan la actividad de endotelina.
SE0001899D0 (sv)	2000-05-22	2000-05-22	Pharmacia & Upjohn Ab	New compounds
US6639082B2 (en)	2000-10-17	2003-10-28	Bristol-Myers Squibb Company	Methods for the preparation of biphenyl isoxazole sulfonamides
JP2004517892A (ja)	2000-12-13	2004-06-17	ワイス	β−アミロイド産生の複素環スルホンアミド阻害剤
US6657070B2 (en)	2000-12-13	2003-12-02	Wyeth	Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
EA200400707A1 (ru)	2001-11-22	2004-10-28	Биовитрум Аб	Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
MXPA04004837A (es) *	2001-11-22	2004-08-02	Biovitrum Ab	Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
KR20050010882A (ko) *	2002-06-11	2005-01-28	와이어쓰	베타 아밀로이드 생산의 치환 페닐술폰아미드 저해제
GB0219660D0 (en)	2002-08-23	2002-10-02	Astrazeneca Ab	Therapeutic use
DE10256186A1 (de) *	2002-12-02	2004-06-09	Bayer Ag	Cyclopenta(c)isoxazol-3-amine als Materialschutzmittel
KR20060002908A (ko) *	2003-03-31	2006-01-09	와이어쓰	베타 아밀로이드 생산 억제제인 플루오로- 및트리플루오로알킬-함유 헤테로사이클릭 설폰아미드 및 이의유도체
GB0403744D0 (en)	2004-02-20	2004-03-24	Astrazeneca Ab	Chemical process
DE602006017071D1 (de) *	2005-01-25	2010-11-04	Five Prime Therapeutics Inc	Zusammensetzungen und verfahren zur behandlung von herzkrankheiten
US7208526B2 (en)	2005-05-20	2007-04-24	Hoffmann-La Roche Inc.	Styrylsulfonamides
JP5204662B2 (ja)	2005-11-22	2013-06-05	アムジエン・インコーポレーテツド	１１−β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤
CA2644784A1 (en) *	2006-03-13	2007-09-20	Jinling Chen	Formulations of sitaxsentan sodium
JP2009530284A (ja) *	2006-03-13	2009-08-27	エンサイシブ・ファーマシューティカルズ・インコーポレイテッド	拡張期心不全を治療するための方法と組成物
SG174050A1 (en) *	2006-04-13	2011-09-29	Actelion Pharmaceuticals Ltd	Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
US20080026061A1 (en) *	2006-06-22	2008-01-31	Reichwein John F	Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thiophene-3-sulfonamide
AU2007275301A1 (en)	2006-07-20	2008-01-24	Amgen Inc.	Substituted azole aromatic heterocycles as inhibitors of 11-beta-HSD-1
EP1995241B1 (de)	2007-03-23	2010-03-17	ICAgen, Inc.	Ionenkanal-Hemmer
WO2009012241A1 (en) *	2007-07-13	2009-01-22	Icagen, Inc.	Sodium channel inhibitors
DE102008015032A1 (de)	2008-03-17	2009-09-24	Aicuris Gmbh & Co. Kg	Substituierte Pyrazolamide und ihre Verwendung
DE102008015033A1 (de)	2008-03-17	2009-09-24	Aicuris Gmbh & Co. Kg	Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008062878A1 (de)	2008-12-17	2010-06-24	Aicuris Gmbh & Co. Kg	Substituierte Furancarboxamide und ihre Verwendung
DE102008062863A1 (de)	2008-12-17	2010-06-24	Aicuris Gmbh & Co. Kg	Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung
PE20120008A1 (es)	2009-01-12	2012-01-24	Icagen Inc	Derivados de fenoxi bencenosulfonamida
JP5872552B2 (ja)	2010-07-09	2016-03-01	ファイザー・リミテッドＰｆｉｚｅｒＬｉｍｉｔｅｄ	化学化合物
CN103339132B (zh) *	2010-12-02	2017-02-15	株式会社麦迪帕克特	嘌呤基吡啶基氨基‑2,4‑二氟苯基磺酰胺衍生物、其药学上可接受的盐、其制备方法及包含其作为活性成分的对Raf激酶具有抑制活性的药物组合物
TW201512171A (zh)	2013-04-19	2015-04-01	Pfizer Ltd	化學化合物
HRP20201695T1 (hr) *	2015-11-13	2020-12-25	Daewoong Pharmaceutical Co., Ltd.	Blokatori natrijevih kanala
US10463656B2 (en)	2017-01-05	2019-11-05	Iowa State University Research Foundation, Inc.	Methods and compositions for prevention of feedlot bovine respiratory disease
US10751315B2 (en)	2017-08-29	2020-08-25	National Jewish Health	Methods and compositions for treating infection and inflammation with selenocyanate
GB201810092D0 (en)	2018-06-20	2018-08-08	Ctxt Pty Ltd	Compounds
GB201810581D0 (en)	2018-06-28	2018-08-15	Ctxt Pty Ltd	Compounds
DK4299135T3 (da)	2019-06-18	2025-09-08	Pfizer	Benzisoxazol-sulfonamid-derivater
CA3217189A1 (en) *	2021-06-22	2022-12-29	Alchemedicine, Inc.	Compound, endothelin a receptor antagonist and pharmaceutical composition

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1003757A (en) *	1910-09-26	1911-09-19	Justus R Kinney	Control for sewage and other pumps.
US3300488A (en) *	1963-12-23	1967-01-24	Shionogi & Co	Nu, nu'-bis [4-halogenated-5-alkyl-3-isoxazolylsulfamoyl)-phenyl]-ureas
US3660383A (en) *	1968-08-14	1972-05-02	Shionogi & Co	Production of iodoisoxazole compounds
JPS60188088A (ja) *	1984-03-09	1985-09-25	Ensuikou Seito Kk	サイクロデキストリンの製法
EP0194548A3 (de) *	1985-03-12	1988-08-17	Dr. Karl Thomae GmbH	Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US4914112A (en) *	1986-06-03	1990-04-03	Sumitomo Pharmaceuticals Company, Limited	Aminoazole derivatives and their production and use
US4752613A (en) *	1987-08-03	1988-06-21	E. R. Squibb & Sons, Inc.	Sulphonamidothienylcarboxylic acid compounds
US4997836A (en) *	1988-11-11	1991-03-05	Takeda Chemical Industries, Ltd.	Trisubstituted piperazine compounds, their production and use
WO1990009380A1 (fr) *	1989-02-10	1990-08-23	Otsuka Pharmaceutical Co., Ltd.	Derives d'indole, leur preparation et medicament les contenant destine a la prevention et au traitement de la nephrite
US5082838A (en) *	1989-06-21	1992-01-21	Takeda Chemical Industries, Ltd.	Sulfur-containing fused pyrimidine derivatives, their production and use
JPH0347163A (ja) *	1989-06-30	1991-02-28	Fujisawa Pharmaceut Co Ltd	アントラキノン誘導体およびその製造
CA2032559C (en) *	1989-12-28	2001-11-06	Kiyofumi Ishikawa	Endothelin antagonistic cyclic pentapeptides
JPH05505822A (ja) *	1990-03-30	1993-08-26	メルク・エンド・カムパニー・インコーポレーテツド	ピラゾール類、イソキサゾール類及びイソチアゾール置換体
US5284828A (en) *	1990-05-14	1994-02-08	Fujisawa Pharmaceutical Co. Ltd.	Peptide compound and its preparation
CA2043741C (en) *	1990-06-07	2003-04-01	Kiyofumi Ishikawa	Endothelin antagonistic peptide derivatives
JPH04134048A (ja) *	1990-09-20	1992-05-07	Takeda Chem Ind Ltd	化合物ｔａｎ―１４１５誘導体、その製造法およびエンドセリン受容体拮抗剤
CA2056142A1 (en) *	1990-11-27	1992-05-28	Hirotomo Masuya	Pyridopyridazine compounds and their use
CA2059380A1 (en) *	1991-01-24	1992-07-25	Yiu-Kuen T. Lam	Endothelin receptor antagonists isolated from microbispora
TW270116B (de) *	1991-04-25	1996-02-11	Hoffmann La Roche
RU2086544C1 (ru) *	1991-06-13	1997-08-10	Хоффманн-Ля Рош АГ	Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
FR2679906B1 (fr) *	1991-07-31	1995-01-20	Adir	Nouvelles (isoquinolein-5 yl) sulfonamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
GB2259450A (en) *	1991-09-11	1993-03-17	Fujisawa Pharmaceutical Co	Compositions with endothelin antagonist activity
HUT67665A (en) *	1991-11-05	1995-04-28	Smithkline Beckman Corp	Indane and indene deriv.s as endothelin receptor antagonists, pharmaceutical compn.s contg. them and process for prepg. them
FR2687675B1 (fr) *	1992-01-31	1997-04-18	Roussel Uclaf	Nouveaux derives bicycliques de la pyridine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5378715A (en) *	1992-02-24	1995-01-03	Bristol-Myers Squibb Co.	Sulfonamide endothelin antagonists
TW224462B (de) *	1992-02-24	1994-06-01	Squibb & Sons Inc
LT3200B (en) *	1992-03-18	1995-03-27	Takeda Chemical Industries Ltd	Triazolopyridazine methodfor production thereof and use
NZ247440A (en) *	1992-05-06	1995-04-27	Squibb & Sons Inc	Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof
ES2042421B1 (es) *	1992-05-22	1994-08-01	Uriach & Cia Sa J	Procedimiento para la obtencion de la 8-cloro-11-1-(5-metil-3-piridil)metil-4-piperidiliden-6,11-dihidro-5h-benzo5,6ciclohepta1,2-bpiridina.
TW287160B (de) *	1992-12-10	1996-10-01	Hoffmann La Roche
US5420123A (en) *	1992-12-21	1995-05-30	Bristol-Myers Squibb Company	Dibenzodiazepine endothelin antagonists
US5420133A (en) *	1993-03-19	1995-05-30	Merck & Co., Inc.	Quinazolinones substituted with phenoxyphenylacetic acid derivatives
ES2062943B1 (es) *	1993-03-23	1995-11-16	Uriach & Cia Sa J	Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
US5389620A (en) *	1993-08-18	1995-02-14	Banyu Pharmaceutical Co., Ltd.	Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
US5965732A (en) *	1993-08-30	1999-10-12	Bristol-Myers Squibb Co.	Sulfonamide endothelin antagonists

1994
- 1994-04-05 US US08/222,287 patent/US5591761A/en not_active Expired - Lifetime
- 1994-05-20 EP EP98109339A patent/EP0870764A1/de not_active Withdrawn
- 1994-05-20 CA CA002161346A patent/CA2161346C/en not_active Expired - Fee Related
- 1994-05-20 RU RU95121744/04A patent/RU2151144C1/ru not_active IP Right Cessation
- 1994-05-20 WO PCT/US1994/005755 patent/WO1994027979A1/en not_active Ceased
- 1994-05-20 DK DK94918081T patent/DK0699191T3/da active
- 1994-05-20 JP JP07500856A patent/JP3135922B2/ja not_active Expired - Fee Related
- 1994-05-20 EP EP94918081A patent/EP0699191B1/de not_active Expired - Lifetime
- 1994-05-20 ES ES94918081T patent/ES2127397T3/es not_active Expired - Lifetime
- 1994-05-20 SG SG1996001101A patent/SG48742A1/en unknown
- 1994-05-20 EP EP00119107A patent/EP1069114A3/de not_active Withdrawn
- 1994-05-20 AT AT94918081T patent/ATE174592T1/de not_active IP Right Cessation
- 1994-05-20 GB GB9503693A patent/GB2285625B/en not_active Expired - Fee Related
- 1994-05-20 DE DE69415316T patent/DE69415316T2/de not_active Expired - Lifetime
1998
- 1998-12-22 CY CY9800048A patent/CY2124B1/xx unknown

Also Published As

Publication number	Publication date
EP0870764A1 (de)	1998-10-14
GB2285625A (en)	1995-07-19
AU6964694A (en)	1994-12-20
EP1069114A3 (de)	2001-01-31
DE69415316T2 (de)	1999-04-29
EP0699191B1 (de)	1998-12-16
GB2285625B (en)	1997-12-10
CA2161346A1 (en)	1994-12-08
US5591761A (en)	1997-01-07
DE69415316D1 (de)	1999-01-28
EP1069114A2 (de)	2001-01-17
SG48742A1 (en)	1998-05-18
WO1994027979A1 (en)	1994-12-08
ES2127397T3 (es)	1999-04-16
DK0699191T3 (da)	1999-08-23
EP0699191A1 (de)	1996-03-06
CY2124B1 (en)	2002-06-21
CA2161346C (en)	2004-11-23
RU2151144C1 (ru)	2000-06-20
GB9503693D0 (en)	1995-04-12
JP3135922B2 (ja)	2001-02-19
JPH08510744A (ja)	1996-11-12
AU691813B2 (en)	1998-05-28

Legal Events

Date	Code	Title	Description
2005-02-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE174592T1 (de)	1999-01-15	Sulfonamide und derivate zur modulierung der endothelin aktivitat
ES2070660B1 (es)	1996-01-01	Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
ATE243203T1 (de)	2003-07-15	Thienyl-, furyl-, pyrrolyl- und biphenylsulfonamide und derivate zur modulation der endothelin-aktivität
DK0977741T3 (da)	2003-12-01	Substituerede phenylderivater, deres fremstilling og anvendelse
GB9801690D0 (en)	1998-03-25	Therapeutic agents
NO971564L (no)	1997-10-06	1,2-difenylpyrrolderivater, deres fremstilling og deres terapeutiske bruk
ATE116306T1 (de)	1995-01-15	Hypoglykämische oxazolidindion-derivate.
EP0976748A4 (de)	2001-08-08	Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
DK0976722T3 (da)	2009-05-04	Benzamidin-derivater
FI953710A0 (fi)	1995-08-03	Uusia pyrrolokarbatsoleja
ES2035915T3 (es)	1993-05-01	Agentes antiarritmicos n-fenetil-aminoalquil-benzamida.
DE68923320D1 (de)	1995-08-10	Derivate von Aminsäuren.
ATE192141T1 (de)	2000-05-15	Aromatische hydroxamsäure-verbindungen, ihre herstellung und verwendung
SE9704770D0 (sv)	1997-12-19	New use
ATE56967T1 (de)	1990-10-15	Amidderivate.
PT856511E (pt)	2004-07-30	Indometacina calcica penta-hidratada e sua preparacao
ES2045335T3 (es)	1994-01-16	Un procedimiento para la preparacion de nuevas s-difluorometilhomocisteinas.
ATE53575T1 (de)	1990-06-15	2,5-pyrrolidindion-derivate mit antiarrhythmischer wirkung.